Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

• Abhishek Maiti,
• Caitlin R. Rausch,
• Jorge E. Cortes,
• Naveen Pemmaraju,
• Naval G. Daver,
• Farhad Ravandi,
• Guillermo Garcia-Manero,
• Gautam Borthakur,
• Kiran Naqvi,
• Maro Ohanian,
• Nicholas J. Short,
• Yesid Alvarado,
• Tapan M. Kadia,
• Koichi Takahashi,
• Musa Yilmaz,
• Nitin Jain,
• Steven Kornblau,
• Guillermo Montalban Bravo,
• Koji Sasaki,
• Michael Andreeff,
• Prithiviraj Bose,
• Alessandra Ferrajoli,
• Ghayas C. Issa,
• Elias J. Jabbour,
• Lucia Masarova,
• Philip A. Thompson,
• Sa Wang,
• Sergej Konoplev,
• Sherry A. Pierce,
• Jing Ning,
• Wei Qiao,
• John S. Welch,
• Hagop M. Kantarjian,
• Courtney D. DiNardo,
• Marina Y. Konopleva

Affiliations

Abhishek Maiti

Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, USA;

Caitlin R. Rausch

Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, USA;

Jorge E. Cortes

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Naveen Pemmaraju

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Naval G. Daver

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Farhad Ravandi

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Guillermo Garcia-Manero

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Gautam Borthakur

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Kiran Naqvi

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Maro Ohanian

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Nicholas J. Short

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Yesid Alvarado

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Tapan M. Kadia

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Koichi Takahashi

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Musa Yilmaz

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Nitin Jain

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Steven Kornblau

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Guillermo Montalban Bravo

Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, USA;

Koji Sasaki

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Michael Andreeff

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Prithiviraj Bose

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Alessandra Ferrajoli

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Ghayas C. Issa

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Elias J. Jabbour

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Lucia Masarova

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Philip A. Thompson

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Sa Wang

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, USA;

Sergej Konoplev

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, USA;

Sherry A. Pierce

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Jing Ning

Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, USA;

Wei Qiao

Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, USA;

John S. Welch

Divisions of Hematology and Oncology, Washington University School of Medicine in St. Louis, USA

Hagop M. Kantarjian

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Courtney D. DiNardo

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;

Marina Y. Konopleva

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, USA;